Compile Data Set for Download or QSAR
maximum 50k data
Found 92 of ec50 data for polymerid = 8099
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446453((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxypyrr...)
Affinity DataEC50: <10nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446473((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50: <10nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446478((S)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50: <10nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446477((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50: <10nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446463((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50: <10nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446481((R)-1-((7-cyano-2-(3′-(6-(difluoromethyl)-3-...)
Affinity DataEC50: <10nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446470((S)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50: <10nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446456((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446457((R)-1-((7-cyano-2-(3′-(7-(((S)-2-hydroxyprop...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446458((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxypyrr...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446459((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxy-3-m...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446460((R)-1-((7-cyano-2-(3′-(7-(((S)-3-hydroxy-3-m...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446461((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446462((R)-1-((7-cyano-2-(3′-(7-(((S)-2-hydroxyprop...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446464((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446465((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446463((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446464((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446465((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446469((S)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446471((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446472((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446474((R)-3-(1-((7-cyano-2-(3′-(2-(difluoromethyl)...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446475((R)-1-((7-cyano-2-(3′-(2-cyclopropyl-7-(((R)...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446476((R)-1-((2-(3′-(2-amino-7-((3-hydroxypyrrolid...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446479((R)-1-((7-cyano-2-(3′-(2-(hydroxymethyl)-7-(...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446455((R)-1-((7-cyano-2-(3′-(7-(((S)-3-hydroxy-3-m...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446454((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxy-3-m...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446453((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxypyrr...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446452((S)-1-((7-cyano-2-(3′-(7-((2-hydroxypropylam...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446451((S)-1-((7-cyano-2-(3′-(7-((1-hydroxypropan-2...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446450((S)-1-((7-cyano-2-(3′-(7-((3-hydroxy-3-methy...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446448((R)-1-((7-cyano-2-(3′-(7-((3-hydroxypyrrolid...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM446449((R)-1-((7-cyano-2-(3′-(7-((3-hydroxy-3-methy...)
Affinity DataEC50:  55nMAssay Description:PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427507(CHEMBL2322546)
Affinity DataEC50:  1.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427536(CHEMBL2322281)
Affinity DataEC50:  1.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427539(CHEMBL2322278)
Affinity DataEC50:  1.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50331546(2-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)benzenes...)
Affinity DataEC50:  3.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427547(CHEMBL2322270)
Affinity DataEC50:  4.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427550(CHEMBL2322267)
Affinity DataEC50:  4.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427513(PYROCATECHOL VIOLET)
Affinity DataEC50:  5.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427512(AURIN | CI-43800 | Corallin | Rosolic acid | Rosol...)
Affinity DataEC50:  5.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427502(CHEMBL2321884)
Affinity DataEC50:  6.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427497(CHEMBL2322555)
Affinity DataEC50:  6.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427494(CHEMBL2322558)
Affinity DataEC50:  6.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427542(CHEMBL2322275)
Affinity DataEC50:  6.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427531(CHEMBL2322252)
Affinity DataEC50:  6.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427501(CHEMBL2322551)
Affinity DataEC50:  6.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427503(CHEMBL2322550)
Affinity DataEC50:  6.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM50427534(CHEMBL2322283)
Affinity DataEC50:  7.00E+4nMAssay Description:Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 92 total ) | Next | Last >>
Jump to: